Endocannabinoids in Alzheimer's disease and their impact on normative cognitive performance: a case-control and cohort study

<p>Abstract</p> <p>Background</p> <p>Neuropathological, animal, and cell culture studies point to a role for the body's own endogenous cannabinoids (eCBs) system in Alzheimer's disease (AD) pathology and treatment. To date, no published studies have investigat...

Full description

Bibliographic Details
Main Authors: Christen Erica, Gordon Marc L, Pazos Miguel, Walker Michael J, Marambaud Philippe, Khalili Houman, Goldberg Terry E, Bradshaw Heather, Koppel Jeremy, Davies Peter
Format: Article
Language:English
Published: BMC 2009-01-01
Series:Lipids in Health and Disease
Online Access:http://www.lipidworld.com/content/8/1/2